Rhythm-sponsored promotional satellite symposium at ECO 2026

Wednesday, 13 May 2026, ISTANBUL - TÜRKIYE

Recording available soon

Rhythm-sponsored promotional satellite symposium at ECO 2026

Advancing care in rare melanocortin-4 receptor (MC4R) pathway diseases: Focus on Bardet-Biedl syndrome (BBS)

During this session, Professor Carel Le Roux (University College Dublin, Ireland), Professor Christine Poitou Bernert (GHU APHP/Sorbonne Université, France) and Professor Karine Clément (Pitié-Salpêtrière Hospital, Sorbonne Université, France) discussed:

  • Rare hypothalamic MC4R pathway diseases
  • Real-world evidence in BBS
  • Early-onset obesity and urgency to treat

Rare hypothalamic MC4R pathway diseases - ECO 2026

Prof. Carel Le Roux

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

Real-world evidence in BBS - ECO 2026

Prof. Christine Poitou Bernert

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

Early-onset obesity and urgency to treat - ECO 2026

Prof. Karine Clément

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

Speakers:

Photo of Prof. Carel Le Roux

Prof. Carel Le Roux

(Ireland)

Prof. Christine Poitou Bernert

(France)

Prof. Karine Clément

(France)